Gilead Sciences to Acquire Tubulis GmbH Transcript
Good afternoon. Thank you for attending todayâs Gilead Sciences update on the proposed Tubulis, Ouro, and Arcellx acquisitions call. My name is Tamia, and I will be your moderator for todayâs call. All lines will be muted during the presentation portion of the call, with an opportunity for questions and answers at the end. (Operator Instructions)
I would now like to pass the conference over to your host, Jacquie Ross, SVP, Treasurer and Head of Investor Relations.
Thank you, Tamia. Good afternoon, everyone, and welcome to todayâs call to discuss this morningâs announcement of Gileadâs definitive agreement to acquire Tubulis, in addition to other recently announced transactions with Arcellx and Ouro. The press release, in addition to the presentation slides from todayâs call, are available on the Investors section of our website at gilead.com. The speakers on todayâs call will be our Chairman and Chief Executive Officer, Daniel OâDay; our Chief Medical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
